Skip to content

Ferrous bisglycinate: effectiveness, uses and precautions

By Claire Mercier · Nutritionist, MSc11 min readPublished 09/13/2026
Sources
6
Validated claims
6
Dominant evidence
Limited
Freshness
09/13/2026
Ferrous bisglycinate: effectiveness, uses and precautions

Ferrous bisglycinate is often presented as better tolerated and better absorbed than traditional iron salts. This promise has some basis, but the key question is whether iron is actually needed and whether this form fits the situation. It is an iron chelate associated with two glycine molecules. Studies suggest a possible benefit in selected settings, especially when digestive effects make treatment difficult, but they do not support routine self-supplementation or one universal dose.

01

1. What form is it?

Ferrous bisglycinate, also called chelated or amino-acid chelated iron, links iron with glycine. Do not confuse it with magnesium bisglycinate. On a label, check elemental iron: the total weight of the compound or capsule cannot compare products.

Sulfate, fumarate and gluconate are commonly used iron salts. Bisglycinate is another chemical form, not a separate treatment category. Product quality, elemental iron, adherence and the initial diagnosis matter as much as the form name.

02

2. What does it do for deficiency?

A 2023 systematic review and meta-analysis included 17 randomized trials comparing bisglycinate with other iron supplements after at least four weeks. In pregnant women, over 4–20 weeks, bisglycinate was associated with higher haemoglobin (standardized difference 0.54 g/dL; 95% CI 0.15–0.94) and fewer reported gastrointestinal events (rate ratio 0.36; 95% CI 0.17–0.76). The ferritin trend was not statistically significant. In children, the review found no significant difference in haemoglobin or ferritin.

A randomized trial in 200 schoolchildren with low iron stores but no anaemia compared 30 mg elemental iron daily as sulfate or bisglycinate for 12 weeks. Ferritin rose in both groups. A later difference favoured bisglycinate, but low-store odds and haemoglobin did not differ significantly by form. This shows why one biomarker cannot establish broad clinical superiority.

03

3. Is absorption always better?

A separate randomized double-blind trial in anaemic children compared bisglycinate with polymaltose iron for 45 days at 3 mg/kg/day in each group. Both treatments increased haemoglobin; bisglycinate also increased ferritin in that sample. This result cannot be extrapolated to adults or used to replace paediatric prescribing.

Absorption studies found higher absorption than sulfate in some maize-based meals. This documents a difference in a specific context, not guaranteed superiority in daily life. Absorption depends on iron stores, hepcidin, meals, inhibitors and the precise product.

Vitamin C can support non-haem iron absorption; phytates, tea and coffee polyphenols and possibly calcium can reduce it. These effects are not absolute. Bisglycinate does not make meals or medication timing irrelevant.

04

4. When might it be considered?

The cause may include heavy menstrual bleeding, pregnancy, growth, inadequate intake, malabsorption, gastrointestinal bleeding or chronic disease. A better-tolerated form may improve adherence, but it does not turn iron into a treatment for every kind of fatigue.

The relevant indication is confirmed iron deficiency, with or without anaemia, after a health professional reviews the results and context. Ferritin reflects stores but is influenced by inflammation; haemoglobin alone cannot explain a deficiency. Heavy menstrual losses, pregnancy, growth, inadequate intake, malabsorption, gastrointestinal bleeding and chronic disease may need consideration.

For someone who cannot tolerate a salt, bisglycinate can be discussed as an option. Fewer digestive events in pregnant women do not guarantee freedom from constipation, nausea, pain or diarrhoea.

05

5. Dose and label reading

Do not transfer the dose from a paediatric, prenatal or therapeutic trial to your own situation. Add together iron from a multivitamin, hair supplement, pregnancy formula and separate bisglycinate. A professional can set the target, monitoring schedule and duration; symptom improvement does not replace laboratory monitoring.

There is no universal bisglycinate dose. Trials used different amounts and durations, and the 2023 review was not designed to identify the best regimen. Compare elemental iron, add up all sources, and do not transfer a paediatric or prenatal protocol to yourself.

EFSA could not establish a tolerable upper level because evidence was insufficient. It proposed a safe level of total intake of 40 mg/day for adults, including pregnancy and lactation, excluding medically supervised treatment of iron-deficiency anaemia. This is not a supplementation target.

06

6. Precautions and interactions

Keep every iron product out of children's reach: accidental ingestion of a large amount can be serious. Pregnancy, breastfeeding, childhood and adolescence require professional guidance. Extra caution is warranted with haemochromatosis, liver disease, repeated transfusions, inflammatory disease or digestive disorders.

Excess iron can cause stomach upset, constipation, nausea, abdominal pain, vomiting or diarrhoea and can be toxic. Iron can reduce zinc absorption in some contexts and accidental ingestion by children can be serious.

Iron can reduce levothyroxine absorption; product information often advises separating it by four hours. It can also interact with levodopa. Proton-pump inhibitors may reduce iron absorption, and calcium may interfere as well. Ask a pharmacist or doctor before changing medication timing.

07

7. A practical decision

Check the amount per serving, other iron sources and excipients. Decide with a professional when monitoring should occur and when the product should be stopped. Food remains useful in an overall strategy, but it cannot always correct established anaemia quickly.

First ask whether deficiency is confirmed and its cause explored. Then check elemental iron, other sources and ingredients. If a salt is poorly tolerated, discuss another form rather than increasing the dose yourself. Agree on laboratory follow-up with the professional.

Food sources remain useful but may not rapidly correct established anaemia. A capsule cannot compensate for ongoing blood loss or unrecognised malabsorption.

08FAQ

01Is bisglycinate always better than sulfate? No. Better tolerance or absorption appears in some contexts, not all populations or outcomes.
02Can I take it without blood tests? Targeted supplementation is best avoided without documented deficiency.
03Does it cause less constipation? Some pregnant-women trials suggest fewer digestive events, not zero side effects for everyone.
04Can it be taken with levothyroxine? Iron may reduce absorption. Ask how to separate the doses; labels often mention four hours.
05Is 40 mg a target? No. It is EFSA’s safe total-intake level for adults, not a supplement goal.

Sources

Peer-reviewed studies and institutional references used for this article.

  1. 1NIH Office of Dietary Supplements· 2025
    Official guidelineEstablished

    general population

    View source
  2. 2EFSA· 2024
    Official guidelineEstablished

    adults

    View source
  3. 3Fischer et al.· 2023
    Meta-analysisLimited

    pregnant women, children and other adults · 17 participants

    View source
  4. 4Name et al.· 2018
    Randomized controlled trialLimited

    children aged 1–13 with iron-deficiency anaemia · 20 participants

    View source
  5. 5Duque et al.· 2014
    Randomized controlled trialLimited

    200 schoolchildren with low iron stores · 200 participants

    View source
  6. 6Bovell-Benjamin et al.· 2000
    Randomized controlled trialLimited

    adults in maize-meal absorption studies

    View source

Comments0 comments

No comments yet. Be the first to react.

Sign in to leave a comment. Sign in

By

Claire Mercier

Registered nutritionist focused on whole-food diets and metabolic health.

Related reading